万维提示：
1、投稿方式：在线投稿。
2、期刊网址：http://www.jlr.org/
https://www.journals.elsevier.com/journal-of-lipid-research/
3、投稿网址：
https://www.editorialmanager.com/jlr/default.aspx
4、官网邮箱：jlr@elsevier.com
5、期刊刊期：月刊，一年出版十二期。
2021年4月18日星期日
投稿须知【官网信息】
Information for Authors
Overview of the JLR publication process
For initial submission, authors should provide their manuscript as a Word/LaTeX file used to prepare the text and tables as well as publication quality figures. Our online submission tool will combine these files into a single PDF. Along with the manuscript PDF file, the authors may submit a Cover Letter and any allowable supplemental data files on the submission site.
Authors will be notified by the Associate Editor as to whether their manuscript has been accepted, declined, or a revision requested. Please see here for more information regarding JLR's peer review process. If a revision is requested, authors should prepare and submit a revised manuscript for review. In addition to the manuscript PDF and any supplementary information files, authors will be asked to upload all source files (i.e., the Word/LaTeX file for the text and tables and the publication quality figures). If the manuscript is accepted for publication, the manuscript PDF will be published as a Paper in Press within 24 hours of acceptance.
Scope
The Journal of Lipid Research (JLR) publishes original articles and reviews in the broadly defined area of biological lipids. The submission of manuscripts relating to lipids, including those addressing problems in biochemistry, molecular biology, structural biology, cell biology, genetics, molecular medicine, clinical medicine, and metabolism is encouraged. Along with sound primary experimental data, major criteria for acceptance of articles are new insights into mechanisms of lipid function and metabolism and/or genes regulating lipid metabolism. Interpretation of the data is the authors' responsibility, and speculation should be labeled as such. Manuscripts that provide new ways of purifying, identifying, and quantifying lipids are invited for the Methods section of the Journal.
Peer review process
Provided that submissions are within the aim and scope of the Journal, manuscripts are assigned by the Editor-in-Chief to an Associate Editor. The Associate Editor sends the submitted manuscript out for evaluation by at least two reviewers. Reviewers are assigned by the Associate Editor handling the manuscript. The Associate Editor makes a decision for acceptance, revision, or declination based not only on reviewer comments, but also whether the manuscript provides new and exciting information that is the high quality expected by JLR.
The identity of all reviewers remains unknown to the authors. Every manuscript is treated by the Editors and reviewers as privileged information, and they are instructed to exclude themselves from the review of any manuscript that might involve a conflict of interest or the appearance thereof. During initial submission, prospective authors are encouraged to recommend one or more Associate Editors who would be particularly appropriate to handle their manuscript. Authors cannot exclude Associate Editors. Authors are also given an opportunity to suggest (and exclude) potential referees with the expertise needed to evaluate the manuscript.
Authorship criteria
Adapted from the recommendation of the International Committee of Medical Journal Editors (ICMJE)
Authorship credit should be based on the following:
substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data;
drafting the article or substantively contributing to revisions in intellectual content;
final approval of the version to be published;
agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
All those designated as authors must meet all four criteria for authorship. Acquisition of funding or general supervision of the research group alone does not constitute authorship. It is expected that each author has made an important scientific contribution to the study and is thoroughly familiar with the original data. It is also expected that each author has read the complete manuscript and takes responsibility for its content and completeness. By accepting authorship, the author understands that if the paper, or any part thereof, is found to be faulty or in violation of ethical standards, they share responsibility with their co-authors.
Assignment of each author's contributions is requested as part of the online submission process.
"Group authorship" is allowed in which the name of the consortium or program is listed as an author, with members of the group listed in the Acknowledgments section. All listed members must meet the full criteria and requirements for authorship as described.
The Editor-in-Chief maintains discretion to allow or disallow inclusion of authors who are deceased. To facilitate review in each case, the contributions of these authors should be described in detail in the manuscript cover letter and within the online submission system.
All substantial changes in authorship (additions, removals, or change in order) that are requested after acceptance must be approved by the Associate Editor and all co-authors. Requests for changes must be made by the corresponding author, co-signed by all co-authors, and sent to the Associate Editor who handled the manuscript. For any requests to remove a co-author, the person who will be removed must also send a letter to the Associate Editor acknowledging this change.
ASBMB journals follow the ICJME recommendations for responsibilities of the corresponding author.
Contact us
If you have any questions related to your current manuscript or past publication in the journal, please contact our editorial office at jlr@elsevier.com.
Editorial policies
Please click here to see the shared editorial policies for the three ASBMB journals.
Types of article
Regular research articles
These articles present original research and address a clearly stated specific hypothesis or question. Papers should provide novel approaches and new insights into the problem addressed. Manuscripts dealing with mechanisms are especially encouraged. More descriptive, "stamp collecting" studies are generally not suitable for publication in the Journal unless judged to provide fundamental insights or fundamental baseline contributions to lipid biology or biochemistry.
Manuscripts in which lipidomic, proteomic and/or genomic analytical techniques are used to assess lipid and/or lipoprotein moieties in various metabolic settings, both in vitro and in vivo, must provide the reasons for the observed changes in lipid moieties.
Manuscripts that explore nutrition or food science as it relates to lipids must present studies that (a) utilize and compare individual nutrients that are very well-defined chemically and (b) include a well-developed mechanistic component clearly relating each nutritional additive to a biological outcome(s).
Methods articles
The Editors will consider significant new/novel contributions in the field of lipid methodology; the paper must provide sufficient details so that the method can be readily reproduced. These papers should be short and concise. Manuscripts describing methods that can be used in analyzing lipids in a biological context and are likely to be of broad utility in the lipid community are the most attractive to the Journal. Papers describing complex chemical syntheses of lipids are usually better suited for a more specialized journal.
Patient-oriented and epidemiological research articles
These studies are those in which human subjects are the dominant focus of the manuscript. These manuscripts must include a statement of institutional approval of the study and adherence to the Declaration of Helsinki principles. This type of study could include a classical clinical investigation in which one of the authors has had direct contact with the subjects, an investigation in which samples collected from a human study were studied by the authors, a genetic analysis of human subjects, or a novel analysis of existing large-scale genetic biobanks. To be considered in this category, the study must make connections between the results and the human sources of the samples (individuals or groups). It does not matter whether the samples were subsequently used in an in vivo, ex vivo, or in vitro analysis.
Images in Lipid Research
These submissions are one-page articles that contain a single horizontal figure, a 400-word description with up to four references, and no more than four authors. The figure and description must convey a mechanistic point about lipid metabolism. Figures may be micrographs, protein structures, and/or lipid molecules. Clinical photographs or images of diagnostic test will also be considered. The images used in the figure must be original and free of copyrighted content that has been submitted or published elsewhere. The following items are required at submission:
A Word or LaTeX document of up to 400 words and a maximum of 4 references that explains the significance of the image is required. The title should be no longer than 15 words and should be non-technical. The reagents and equipment used to generate the image should be provided as a separate paragraph following the main text. References should be formatted the same as a regular research article. A figure legend should not be included.
A figure file as either a tiff or eps file must be uploaded to the submission system. The image must be horizontal with a width:height ratio of 2:1(Width, 1000 pixels; Height, 500 pixels; Resolution, 300 dpi). Fluorescent images must show signals from individual channels in gray scale to reveal the full dynamic range of intensities and to allow color-blind individuals to appreciate the image. Merged images should be presented in color, with distinct colors for individual channels.
The Word/LaTeX document should be combined with the figure file to create a single PDF file. If the article is accepted, this version will be published online within 24 hours as a Paper in Press.
Review articles
The Journal publishes critical reviews on current, timely topics. Reviews should be concise and should provide a balanced analysis and summary of the topic. The information should be understandable to scientists in other related fields. A good and critical review will develop new insights into the field and propose potential new research opportunities. The Journal generally invites reviews written by established investigators in the field, although an unsolicited review from an expert in the field may be published if the review is judged to be exceptionally timely, topical, novel, and of broad interest to JLR readers.
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the Article Structure section in this Guide for Authors for more details.
Please consult the detailed list to ensure that the following key items are present:
Corresponding author information
Submission files:
Mandatory items
Article title
co-Author names and affiliations
Section titles
All figures as individual high-resolution files. Legends should be supplied within the manuscript file.
All tables as individual files. All titles, description and footnotes should be provided within the manuscript file.
Ensure all figure and table citations in the manuscript text match the files provided.
Author CRediT statement (the template file will be provided during submission)
Optional items
Graphical abstract
Supplemental files
Other considerations:
Please double check the following:
Manuscript has been "spell checked" and "grammar checked." You may consider Language Editing services or any other service of your choice if needed.
All references mentioned in the Reference List are cited in the text, and vice versa.
Permission has been obtained for use of copyrighted material from other sources (including the Internet).
A Declaration of Interest is provided, even if the authors have no competing interests to declare.
Journal policies detailed in this guide have been reviewed.
Referee suggestions and contact details provided, based on journal requirements.
For further information, visit our Support Center. We recommend you use the Chat option at the bottom of the page for immediate help. If you need additional help, please contact our editorial office at jlr@elsevier.com.
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Studies involving human subjects or animals
Human subjects
All studies involving human subjects must be approved by the appropriate review board(s) and abide by the Declaration of Helsinki principles. A specific statement declaring approval and Helsinki compliance must be included in the Experimental Procedures section. Published studies that involve human subjects should not provide any identifying information (e.g., names, true initials, recognizable images) unless the information is essential for scientific purposes and the patient (or patient's parent/guardian) gives written informed consent for publication. If the patient is deceased, then the authors should seek consent from a relative. If such written consent is required, please download the form here and upload as additional Supplemental material for review only.
Animal and preclinical research studies
ASBMB encourages the reporting of animal data using the nomenclature and standards outlined in the ARRIVE (Animal in Research: Reporting In Vivo Experiments) guidelines, Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research PLoS Biol. 2010 Jun 29;8(6):e1000412. All studies must be approved by the appropriate review board(s) and a specific statement of such an approval must be made in the Experimental Procedures section.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. This summary statement will be ultimately published if the article is accepted. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Please find Declaration of Interest form here.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture, academic thesis, or preprint, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Author contributions
For transparency, authors are required to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example. Please click here to view the author statement file.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Clinical trial results
In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.
Reporting clinical trials
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram are available online.
Registration of clinical trials
Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open Access
Please visit our Open Access page from the Journal Homepage for more information.
Available tools for authors
Elsevier Researcher Academy
Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services.
Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier). Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.
LaTeX
You are recommended to use the Elsevier article class elsarticle.cls to prepare your manuscript and BibTeX to generate your bibliography.
Our LaTeX site has detailed submission instructions, templates and other information.
Article structure
Formatting your manuscript file
Our editorial system, Editorial Manager, automatically extracts the information from your submitted file to save you time during submission. Therefore, a PDF is not an acceptable source file for the manuscript. Only editable source files must be uploaded for the main manuscript file - including figure captions, and these will typically have the extension .docx, .doc, or .tex. We strongly recommend you use the formatting described here to enter authors names and section titles in your manuscript file. This will allow our editorial system to automatically extract manuscript information and prefill many of the required submission fields on the following pages, saving you a lot of time during the submission.
Preparing the text and tables
The following guidelines apply to regular research, methods, and patient-oriented and epidemiological research articles. Manuscripts must be written in English. Please note that, if accepted, JLR will automatically publish the accepted version of the manuscript online as a JLR Paper in Press (in PDF format), without copyediting or typesetting. Therefore, it is critical that the manuscript is prepared with great care before submitting online. It is particularly important that the title and authors are correct, since this information will become part of the paper's permanent record in PubMed.
JLR does not set a specific word limit for submitted manuscripts, but encourages authors to be concise.
Text and table formatting requirements
Prepared using Microsoft Word;
double-spaced;
11-point Times New Roman font;
8.5-by-11-inch paper size (U.S. letter).
Order of sections
Title page
Abstract and keywords
Introduction
Materials and Methods
Results
Discussion
Data availability statement
Acknowledgments/grant support
References
Footnotes to text (if any)
Tables
Figures and figure legends
Title page
The title page should include the following information.
Title: Limited to two printed lines, about 120 characters including spaces.
Authors: Full names and affiliations (Department, Institution, City, State/Province (if applicable), Country)—indicate which author will accept correspondence and proofs.
Contact information for corresponding author: Please note that more than one corresponding author may be present on the final published manuscript, but for the purpose of the editorial system only one needs to be chosen during submission. The following details must be provided for that corresponding author: Full name; Full affiliation (Department, Institution, City, State/Province (if applicable), Country, Full postal address, Contact phone; E-mail address (institutional address must be provided as alternate e-mail in case a non-institutional e-mail is used).
Short title: Abbreviated title of maximum 60 characters including spaces.
Funding sources: List funding sources in this standard way to facilitate compliance to funder's requirements: Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa]. It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding. If no funding has been provided for the research, please include the following sentence: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Abbreviations: Any abbreviations not found on the JLR abbreviation list.
Characters
Only characters that can be encoded in Unicode such as Chinese, Japanese, Korean, Cyrillic, and Arabic are acceptable. Non-Latin characters can only be used for author names, not author affiliations or titles.
Abstract
250 word limit.
States objectives and new findings.
Unstructured preferred. Ends with a short conclusion of two or three sentences.
Contains no references.
Keywords
At least five keywords from this list (keywords are equivalent to editorial board members' expertise terms).
Up to five free-form keywords.
Maximum of ten keywords in total.
Should not appear in title or running title.
Listed on the abstract page.
……
